Literature DB >> 24048293

Increased plasma norepinephrine levels in previously pre-eclamptic women.

K H Lampinen1, M Rönnback2, P-H Groop2, M G Nicholls3, T G Yandle3, R J Kaaja4.   

Abstract

A history of pre-eclampsia increases the risk of cardiovascular morbidity by mechanisms yet unknown. The aim of the present study was to assess whether plasma norepinephrine (NE) levels are increased 5-6 years after pre-eclamptic pregnancy and to investigate associations with pathophysiological mechanisms of cardiovascular disease: insulin sensitivity, vascular function and arterial pressure. A total of 28 women with previous pre-eclampsia and 20 controls were examined. Blood pressure (BP) and plasma levels of NE and endothelin-1 (ET-1) were measured at rest and after standing for 5 min. Insulin sensitivity was assessed with minimal model analysis and vascular function was assessed using venous occlusion plethysmography and pulse wave analysis. Twenty-four-hour BP measurements were carried out. Women with previous pre-eclampsia had higher levels of NE at rest (P=0.02), which did not associate significantly with insulin sensitivity or overall vasodilatory capacity. The 24-h mean of systolic and diastolic blood pressures (BPs) and heart rate did not differ between the groups (P=0.30, P=0.10 and P=0.46, respectively), and there was no significant association with NE levels. ET-1 levels were similar between the groups, but a positive correlation with systolic (P=0.04) and diastolic (P=0.03) BPs in the upright position was shown in the patient group. Increased levels of plasma NE are sustained in women with previous pre-eclampsia and may contribute to the increased risk for cardiovascular disease in these women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048293     DOI: 10.1038/jhh.2013.84

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  44 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

Review 2.  Endothelin: key mediator of hypertension in preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Am J Hypertens       Date:  2011-06-16       Impact factor: 2.689

3.  Preeclampsia -- a state of sympathetic overactivity.

Authors:  H P Schobel; T Fischer; K Heuszer; H Geiger; R E Schmieder
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

4.  Blood pressure and vasoactive hormones in mild preeclampsia and normal pregnancy.

Authors:  R J Kaaja; M P Moore; T G Yandle; O Ylikorkala; C M Frampton; M G Nicholls
Journal:  Hypertens Pregnancy       Date:  1999       Impact factor: 2.108

Review 5.  Role of endothelin in human hypertension.

Authors:  Rhian M Touyz; Ernesto L Schiffrin
Journal:  Can J Physiol Pharmacol       Date:  2003-06       Impact factor: 2.273

Review 6.  Insulin resistance and the sympathetic nervous system.

Authors:  Brent M Egan
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

7.  Pregnancy-induced sympathetic overactivity: a precursor of preeclampsia.

Authors:  T Fischer; H P Schobel; H Frank; M Andreae; K T M Schneider; K Heusser
Journal:  Eur J Clin Invest       Date:  2004-06       Impact factor: 4.686

Review 8.  Insulin resistance syndrome in preeclampsia.

Authors:  R Kaaja
Journal:  Semin Reprod Endocrinol       Date:  1998

Review 9.  Plasma lipids and vascular dysfunction in preeclampsia.

Authors:  B Lorentzen; T Henriksen
Journal:  Semin Reprod Endocrinol       Date:  1998

Review 10.  Noradrenaline release and sympathetic nervous system activity.

Authors:  M D Esler; G J Hasking; I R Willett; P W Leonard; G L Jennings
Journal:  J Hypertens       Date:  1985-04       Impact factor: 4.844

View more
  6 in total

1.  The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.

Authors:  Maja Mustapic; Adam X Maihofer; Manjula Mahata; Yuqing Chen; Dewleen G Baker; Daniel T O'Connor; Caroline M Nievergelt
Journal:  Hum Mol Genet       Date:  2014-06-30       Impact factor: 6.150

2.  Sympathetic responsiveness is not increased in women with a history of hypertensive pregnancy.

Authors:  Sushant M Ranadive; Ronee E Harvey; Brian D Lahr; Virginia M Miller; Michael J Joyner; Jill N Barnes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-07       Impact factor: 3.619

3.  Clinical study on the association between pregnancy-induced hypertension and insulin resistance.

Authors:  Zhifang Chen; Weiling Liu; Xiaoqin Sun; Lingling Zhu
Journal:  Exp Ther Med       Date:  2017-03-02       Impact factor: 2.447

4.  Sympathetic nervous system control of vascular function and blood pressure during pregnancy and preeclampsia.

Authors:  Frank T Spradley
Journal:  J Hypertens       Date:  2019-03       Impact factor: 4.844

Review 5.  Dopamine in the Pathophysiology of Preeclampsia and Gestational Hypertension: Monoamine Oxidase (MAO) and Catechol-O-methyl Transferase (COMT) as Possible Mechanisms.

Authors:  Wendy N Phoswa
Journal:  Oxid Med Cell Longev       Date:  2019-11-28       Impact factor: 6.543

6.  Postpartum Vascular Dysfunction in the Reduced Uteroplacental Perfusion Model of Preeclampsia.

Authors:  Lesley Brennan; Jude S Morton; Anita Quon; Sandra T Davidge
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.